DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Gettys TW, Watson PM, Taylor IL, Collins S.
RU-486 (Mifepristone) ameliorates diabetes but does not correct deficient β-adrenergic signalling in adipocytes from mature C57BL/J6-ob/ob mice.
Int J Obesity 1997; 21: 865-873
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.